2Yoshida K, Aizawa Y, KaiseN, et al. Role of thyroid-stimulating blocking antibody in patients who developed hypothyroidism within one year after 131I treatment for Graves' disease[J]. Clin Endocrinol,1998, 48(1): 17-22.
3Gomez JM, Gomez N, Amat M, et al. Hypothyroidism after iodine131 or surgical therapy for Graves' disease hyperthyroidism[J]. Ann Endocrinol, 2000, 61(3): 184-191.
4Sabri O, Zimny M, Schreckenberger M, et al. Determination of factors affecting the therapeutic outcome of radioiodine therapy in patients with Graves disease[J]. Nuklearmedizin,1998, 37: 83-89.
5Ahmad AM, Ahmad M, Young ET. Objective estimates of the probability of developing hypothyroidism following radioactive iodine treatment of thyrotoxicosis [J]. Eur J Endocrinol, 2002, 146(6):767-775.
6Mondel S J, Brent GA, Larsen PR. Levothyroxine theraphy in patients with thyroid disease [J]. Ann Intern Med, 1993,119: 492-499.
7Apasso G, De Tommaso G, Pica Z, et al. Effects of thyroid hormones on heart and kidney functions[J]. Miner Electrolyte Metab,1999, 25(1-2): 56-64.
8Buneveclus R, Kazanavicius G, Zalinkevicius R, et al. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism[J]. N Engl J Med, 1997, 126: 226-231.
